Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) is now available.
EBR Systems will showcase its wireless cardiac pacing technology to investors at three healthcare and biotech conferences in March in Miami, Sorrento and Hong Kong, with senior executives hosting meetings, presentations and a fireside chat. The company also reported ongoing commercial momentum in early 2026, with quarterly-to-date case volumes rising to 25 procedures, seven new purchasing agreements lifting the total to 28, and the number of trained implanting physicians reaching 46, underscoring growing clinical adoption of its WiSE System.
These increased case volumes and expanded hospital purchasing base suggest the company is progressing from early commercialisation toward broader market penetration in cardiac resynchronisation therapy. For stakeholders, the combination of stronger operating metrics and heightened investor outreach points to an effort to solidify EBR’s positioning in the competitive cardiac device market and support continued uptake of its differentiated leadless pacing technology.
The most recent analyst rating on (AU:EBR) stock is a Hold with a A$0.79 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
EBR Systems, Inc. is a Silicon Valley-based medical technology company focused on treating cardiac rhythm disease through wireless cardiac pacing solutions. Its proprietary Wireless Stimulation Endocardially (WiSE) technology eliminates the need for traditional pacing leads and is initially targeted at heart failure patients requiring cardiac resynchronisation therapy, with potential future applications in bradycardia and non-cardiac indications.
Average Trading Volume: 508,384
Technical Sentiment Signal: Sell
Current Market Cap: A$312.7M
Find detailed analytics on EBR stock on TipRanks’ Stock Analysis page.